Prognostic value of C-reactive protein to albumin ratio in patients with hepatocellular carcinoma: A meta-analysis

Clin Res Hepatol Gastroenterol. 2020 Apr;44(2):241-243. doi: 10.1016/j.clinre.2019.07.014. Epub 2019 Aug 20.

Authors

Yu Fan¹, Xuyu Gu¹, Zhenjun Gao²

Affiliations

¹ Cancer Institute, Jiangsu University, The Affiliated People's Hospital, 212002 Zhenjiang, Jiangsu, China.
² Department of Gastroenterology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, No. 1158 East Road, Qingpu District, 201700 Shanghai, China. Electronic address: gaozhenjun2016@sina.com.

PMID: 31444039
DOI: 10.1016/j.clinre.2019.07.014

No abstract available

Keywords: C-reactive protein/albumin ratio; Hepatocellular carcinoma; Meta-analysis; Overall survival.

Publication types

Letter
Meta-Analysis

MeSH terms

C-Reactive Protein / analysis*
Carcinoma, Hepatocellular / blood*
Carcinoma, Hepatocellular / mortality
Humans
Liver Neoplasms / blood*
Liver Neoplasms / mortality
Prognosis
Serum Albumin / analysis*
Survival Rate

Substances

Serum Albumin
C-Reactive Protein